Protein X-ray Crystallography in Drug Discovery

Drug Discovery Handbook

Volumn , Issue , 2005, Pages 373-455

  Nollert, Peter ^a   Feese, Michael D ^a   Staker, Bart L ^a   Kim, Hidong ^a  

^a DeCODE Chemistry & Biostructures   (United States)

Author keywords

Crystallographic fragment screening; High throughput crystallographic technologies; Protein X ray crystallography

Indexed keywords

EID: 84882603841     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471728780.ch10     Document Type: Chapter

References (93)

1. Nienaber,V. L., Richardson, P. L., Klighofer,V., Bouska, J. J., Giranda,V. L., Greer, J. (2000). Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat. Biotechnol., 18, 1105-1108.
2. Erlanson, D.,Wells, J., Braisted, A. (2004). Tethering: Fragment-based drug discovery. Annu. Rev. Biophys. Biomol. Struct., 33, 199-223.
3. Erlanson,D. A., Braisted,A. C., Raphael,D. R., Randal, M., Stroud, R. M., Gordon, E. M.,Wells, J. A. (2000). Site-directed ligand discovery. PNAS, 19, 9367-9372.
4. Anderson,A. C. (2003). The process of structure-based drug discovery. Chem. Biol., 10, 787-797.
5. Doman, T. N., McGovern, S. L., Witherbee, B. J., Kasten, T. P., Kurumbail, R., Stallings,W. C., Conolly,D. T., Shoichet, B. K. (2002). Molecular docking and highthroughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J. Med. Chem., 45, 2213-2221.
6. Bergfors,T.M. (1999). Protein Crystallization,Techniques, Strategies and Tips; a Lab Manual. International University Line, La Jolla, CA.
7. McPherson, A. (1989). Preparation and Analysis of Protein Crystals. Krieger Publishing.
8. McPherson, A. (1998). Crystallization of Biological Macromolecules. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
9. Ducruix, A., Giegé,G. (1992). Crystallization of Nucleic Acids and Proteins, a Practical Approach. IRL Press.
10. Weber, P. C. (1991). Physical principles of protein crystallizaiton. Adv. Protein Chem., 41, 1-36.
11. Durbin, S. D., Feher,G. (1996). Protein crystallization. Annu. Rev. Phys. Chem., 47, 171-204.
12. McPherson,A. (1990). Current approaches to macromolecular crystallization. Eur. J. Biochem., 189, 1-23.
13. Chernov, A. A. (2003). Protein crystals and their growth. J. Struct. Biol., 142, 3-21.
14. Drenth, J., Haas,C. (1992). Protein crystals and their stability. J. Cryst. Growth, 122, 107-109.
15. Chayen, N. E. (1998). Comparative studies of protein crystallizaiton by vapourdiffusion and microbatch technique. Acta Crystallogr., D54, 8-15.
16. Chayen, N. E., Shaw Stewart, P. D., Blow, D. M. (1992). Microbatch crystallization under oil-A new technique allowing many small-volume crystallization trials. J. Cryst. Growth, 122, 176-180.
17. Chayen N. E. (1997). The role of oil in macromolecular crystallization. Structure, 5, 1269-1274.
18. Zeppezauer, M. (1971). In W. B. Jakoby (Ed.), Methods in Enzymology, Vol 22. Academic, New York and London.
19. Drews, J. (2000). Drug discovery: A historical perspective. Science, 287, 1960-1964.
20. Iwata, S., (Ed.) (2003). Methods and Results in Crystallization of Membrane Proteins. International University Line, Biotechnology Series.
21. Hunte, C. C., von Jagow, G., Schagger, H (2003). Membrane Protein Purification and Crystallization: A Practical Guide. Academic, San Diego.
22. Nollert, P., Navarro, J., Landau, E. M. (2001). Crystallization of membrane proteins in cubo. Methods Enzymol., 343, 183-199.
23. Terpe, K. (2003). Overview of tag protein fusions: From molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol., 60, 523-533.
24. Smyth,D. R., Mroziewicz,M. K.,McGrath,W. J., Listwan,P.,Kobe,B. (2003). Crystal structures of fusion proteins with large-affinity tags. Protein Sci., 12, 1313-1322.
25. Deng, J., Davies, D. R.,Wisedchaisri, G.,Wu, M., Hol,W. G. J., Mehlin, C. (2004). An improved protocol for rapid freezing of protein samples for long-term storage. Acta Cryslallogr. D60, 203-204.
26. Page, R., Grzechnik, S. K., Canaves, J., Spraggon,G., Kreusch, A.,Kuhn, P., Stevens, R. C., Lesley, S. (2003). Shotgun crystallization strategy for structural genomics:An optimized two-tiered crystallization screen against the Thermatoga maritima proteome. Acta Crystallogr. D, D59, 1028-1037.
27. Jancarik, J., Kim, S.-H. (1991). Spare matrix sampling: A screening method for crystallization of proteins. J. Appl. Crystallogr., 24, 409-411.
28. Majeed, S., Ofek, G., Belachew, A., Huang, C., Zhou, T., Kwong, P. D. (2003). Enhancing protein crystallization through precipitant synergy. Structure, 11, 1-20.
29. Segelke,B.W. (2001). Efficiency analysis of sampling protocols used in protein crystallization screening. J. Cryst. Growth, 232, 553-562.
30. Gilliland, G. L., Tung, M., Ladner, J. (1996). The Biological Macromolecule Crystallization Database and NASA Protein Crystal Growth Archive. J. Res. Natl. Inst. Stand. Technol., 101, 309-320.
31. Garman, E. F., Schneider, T. R. (1997). Macromolecular cryocrystallography. J. Appl. Crystallogr., 30, 211-237.
32. Parkin, S., Hope, H. (1998). Macromolecular cryocrystallography: Cooling, mounting, storage and transportation of crystals. J. Appl. Crystallogr., 31, 945-953.
33. Rubinson, K. A., Ladner, J. E.,Tordova, M., Gilliland,G. L. (2000). Cryosalts: Suppression of ice formation in macromolecular crystallography. Acta Crystallogr., D56, 996-1001.
34. Riboldi-Tunncliffe,A., Hilgenfeld, R. (1999). Cryocrystallography with oil-An old idea revived. J. Appl. Crystallogr., 32, 1003-1005.
35. Carter,C.W., Jr., Doublie, S., Coleman,D. E. (1994). Quantitative analysis of crystal growth. Tryptophanyl-tRNA synthetase crystal polymorphism and its relationship to catalysis. J. Mol. Biol., 238(3), 346-365.
36. Stewart, L., Clark, R., Behnke, C. (2002). High-thoughput crystallization and structure determination in drug discovery. Drug Discov. Today, 7(3), 187-196.
37. Petsko,G. A. (1985). Preparation of isomorphous heavy-atom derivatives, Methods Enzymol., 114, 147-156.
38. Rould, M. (1997). Screening for heavy-atom derivatives and obtaining accurate isomorphous differences. Methods Enzymol., 276, 112-147.
39. Gilliland, G. L. (1988). A biological macromolecule crystallization database: A basis for a crystallization strategy. J. Cryst. Growth, 90, 51-59.
40. HyperPhyscis web site: http://hyperphysics.phy-astr.gsu.edu/hbase/phyopt/ mulslid.html#c4.
41. Glusker, J. P.,Trueblood, K. N. (1972). Crystal Structure Analysis: A Primer. Oxford University Press, New York.
42. Stout,G. H., Jensen, L. H. (1989). X-ray Structure Determination:A Practical Guide. Wiley, New York, p. 202.
43. Otwinowski, Z., Minor,W. (1997). Processing of oscillation data collected in oscillation mode. Methods Enzymol., 276, 307-326.
44. Diedrichs, K., Karplus, K. A. (2002). Improved R-factors for diffraction in macromolecular crystallography. Nat. Struct. Biol., 4, 269-275.
45. Gewirth, D. (2003). The HKL Manual. pp. 89-90.
46. Fuji web site: http://home.fujifilm.com/products/science/ip/principle.html.
47. ADSC web site: http://www.adsc-xray.com/products.html.
48. Walsh, M. A., Dementieva, I., Evans, G., Sanishvili, R., Joachimiak, A. (1999). Taking MAD to the extreme: Ultrafast protein structure determination. Acta Crystallogra., D55, 1168-1173.
49. Cohen, A. E., Ellis, P. J., Miller, M. D., Deacon, A. M., Phizackerley, R. P. (2002). An automated system to mount cryo-cooled protein crystals on a synchrotron beamline, using compact sample cassettes and a small-scale robot. J. Appl. Crystallogr., 35, 720-726.
50. Pohl, E., Ristau, U., Gehrmann, T., Jahn, D., Robrahn, B., Malthan, D., Dobler, H., Hermes, C. (2004). Automation of the EMBL Hamburg protein crystallography beamline BW7B. J. Synchrotron Radiation, 11, 1-6.
51. ALS web site: http://www-als.lbl.gov/als/synchrotron_sources.html.
52. Drenth, J. (1994). Principles of Protein X-ray Crystallography. Springer-Verlag, New York, pp. 282-283.
53. Dauter, Z., Dauter, M., Dodson, E. (2002). Jolly SAD. Acta Crystallogr., D58, 494-506.
54. McRee, D. (1993). Practical Protein Crystallography. Academic, San Diego, p. 145.
55. Hendrickson, W. A (1991). Determination of macromolecular structures from anomalous diffraction of synchrotron radiation. Science, 254, 51-58.
56. Wang, B. C. (1985). Resolution of phase ambiguity in macromolecular crystallography. Methods Enzymol., 115, 90-112.
57. Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson,T.,Warren,G. L. (1998). Crystallography and NMR System: A new software suite for macromolecular structure determination. Acta Crystallogr., D54, 905-921.
58. Murshudov, G. N.,Vagin, A. A., Dodson, E. J. (1997). Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr, D53, 240-255.
59. Altschul, S. F., Gish,W., Miller,W., Myers, E. W., Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
60. Cuff, J. A., Clamp, M. E., Siddiqui, A. S., Finlay, M, Barton, G. J. (1998). Jpred: A consensus secondary structure prediction server. Bioinformatics, 14, 892-893.
61. Murzin, A. G., Brenner, S. E., Hubbard, T., Chothia, C. (1995). SCOP: A structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol., 247, 536-540.
62. Orengo, C. A., Michie, A. D., Jones, S., Jones, D. T., Swindells, M. B., Thornton, J. M. (1997). CATH: A hierarchic classification of protein domain structures. Structure, 5(8), 1093-1108.
63. Lewis, P. N., Momany, F. A., Scheraga, H. A. (1973). Chain reversals in proteins. Biochim. Biophys. Acta, 303, 211-229.
64. McPhail, A. T., Sim, G. A. (1968). The structure of camptothecin: X-ray analysis of camptothecin iodoacetate. J. Chem. Soc. (B), 384, 923-928.
65. Winn, M. D., Isupov, M. N., Murshudov, G. N. (2001). Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr., D57, 122-133.
66. Moews, P. C., Kretsinger, R. H. (1975). Refinement of the structure of carp muscle calcium-binding parvalbumin by model building and difference Fourier analysis. J. Mol. Biol., 91, 201-228.
67. Ramachandran,G. N., Ramakrishnan, C., Sasisekharan,V. (1963). Stereochemistry of polypeptide chain configurations. J. Mol. Biol., 7, 95-99.
68. Printz, M. P., Nemethy,G. (1972). The g turn, a possible folded conformation of the peptide chain. Comparison with the b turn. Macromolecules, 5, 755-758.
69. Hardy, L.W., Malikayil, A. (2003). The impact of structure-guided drug design on clinical agents. Curr. Drug Discov., 15-20.
70. Klebe, G. (2000). Recent developments in structure-based drug design. J. Mol. Med., 78, 269-281.
71. Veerapandian, P. (Ed.) (1997). Structure-Based Drug Design. Marcel Dekker, New York.
72. Kubinyi, H. (1999). J. Receptor Signal Transduction Res., 19, 15-39.
73. Williams, P. A., Cosme, J., Vinkovic, D. M., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., Jhoi, H. (2004). Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science, 305, 683-686.
74. Mao, H., Hajduk, P. J., Craig, R., Bell, R., Bore, T., Fesik, S. W. (2001). Rational design of diflunisal analogues with reduced affinity for human serum albumin. J. Am. Chem. Soc., 123, 10429-10435.
75. Ewert, S., Honegger, A., Plückthun,A. (2003). Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach. Biochemistry, 42, 1517-1528.
76. Stricher, M. L. F., Misse, D., Sironi, F., Pugniere, M., Barthe, I., Magne, X., Roumestand, C., Menez, A., Lusso, P. (2003). Rational design of a CD4 mimic that inhibits HIV-1 entry neutralization epitopes. Nat. Biotechnol., 21, 71-76.
77. Taylor, R. D., Jewsbury, P. J., Essex, J. W. (2002). A review of protein-small molecule docking methods. J. Computer-Aided Mol. Des., 16, 151-166.
78. Bajorath, J. (2002). Integration of virtual and high-throughput screening. Nat. Rev. Drug Discov., 1, 882-894.
79. Carr, R., Jothi, H., et al. (2002). Structure-based screening of low affinity compounds. Drug Discov. Today, 7, 522-527.
80. Blundell,T. L., Jhoti, H.,Abell,C. (2002). High-throughput crystallography for lead discovery in drug design. Nature Reviews, 1, 45-54.
81. Rees,D. C., Congreve, M., Murray, C.W., Carr,R. (2004). Fragment-based lead discovery. Nat. Rev., 3, 660-672.
82. Erlanson, D. A., Lam, J.W.,Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., Gordon, E. M., O'Brien,T. (2003). In situ assembly of enzyme inhibitors using extended tethering. Nat. Biotechnol., 21(3), 308-314.
83. Zhang, Kim (2003). Overview of structural genomics: From structure to function. Curr. Opin. Chem. Biol., 7, 28.
84. Zarembinski,T. I., Hung, L.-W., Mueller-Dieckmann, H.-J., Kim, K.-K.,Yokota, H., Kim, R., Kim, S.-H. (1998). Structure-based assignment of the biochemical function of a hypothetical protein: A test case of structural genomics. PNAS, 95(26), 15189-15193.
85. Mathews, I. I., Deacon, A. M., Canaves, J. M., McMullan, D., et al. (2003). Functional analysis of substrate and cofactor complex structures of a thymidylate synthase complementing protein. Structure, 11, 677-690.
86. Schneider, T. R. (1996). What can we learn from anisotropic temperature factors? In E. Dodson, M. Moore, A. Ralph, and S. Bailey (Eds.), Proceedings of the CCP4 Study Weekend. SERC Daresbury Laboratory, Daresbury, UK, pp. 133-144.
87. De Pristo, M. A., de Bakker, P. I.W., Blundell,T. L. (2004). Heterogeneity and inaccuracy in protein structures solved by X-Ray crystallograph. Structure, 12, 831-838.
88. Davis, A., Teague, S. (1999). Hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. Angew. Chem. Int. Ed. Engl,. 38, 736-749.
89. Teague, S. J. (2003). Implications of protein flexibility for drug discovery. Nat. Rev. Drug Discov., 2, 527-541.
90. Sanders,W. J., Nienaber,V. L., Lerner,C. G., McCall, J. O., Merrick, S. M., Swanson, S. J., Harlan, J. E., Stoll,V. S., Stamper,G. F., Betz, S. F., Condroski, K. R., Meadows, R. P., Severin, J. M.,Walter, K. A., Magdalinos, P., Jakob, C. G.,Wagner, R., Beutel, B. A. (2004). Discovery of potent inhibitors of dihydroneopterin aldolase using CrystaLEAD high-throughput X-ray crystallographic screening and structuredirected lead optimization. J. Med. Chem., 47, 1709-1718.
91. Reddy, M. R., Erion, M. D. (Eds.) (2004). Free Energy Calculations in Rational Drug Design. Kluwer Academic.
92. Verkhiveker, G. M., Bouzida, D., Gehlhaar, D. K., Rejto, P. A., Freer, S. T., Rose, P. W. (2002). Complexity and simplicity of ligand-macromolecule interactions: The energy landscape perspective. Curr. Opin. Struct. Biol., 12, 197-203.
93. Thiel, K. A. (2004). Structure-aided drug design's next generation. Nat. Biotechnol., 22(5), 513-519.